GH Research PLC (GHRS)
12.50
-0.23
(-1.81%)
USD |
NASDAQ |
May 17, 16:00
12.50
0.00 (0.00%)
After-Hours: 20:00
GH Research Cash from Financing (TTM): -0.205M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -0.205M |
December 31, 2023 | -0.204M |
September 30, 2023 | -0.163M |
June 30, 2023 | -0.107M |
March 31, 2023 | -0.07M |
Date | Value |
---|---|
December 31, 2022 | 0.00 |
September 30, 2022 | -0.171M |
June 30, 2022 | -2.773M |
March 31, 2022 | 286.45M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-2.773M
Minimum
Jun 2022
286.45M
Maximum
Mar 2022
31.42M
Average
-0.163M
Median
Sep 2023
Cash from Financing (TTM) Benchmarks
Amarin Corp PLC | -1.56M |
Jazz Pharmaceuticals PLC | -332.02M |
Prothena Corp PLC | 22.66M |
Iterum Therapeutics PLC | 8.016M |
Mural Oncology PLC | 412.68M |